Global PCOS treatment market valued around USD 3.39 Billion in 2019 and is expected to grow at a formidable rate of around 8.63% during the forecast period. The global PCOS treatment market is driven by the increasing prevalence of diabetes and obesity among the woman population. Additionally, increasing cases of hormonal imbalances in the women are further expected to propel the market during forecast period. Furthermore, the development of new drugs and treatment options for the treatment of PCOS is expected to fuel the growth of market through 2025.
The global PCOS treatment market is segmented based on surgery, drug, diagnosis, end user, company and region. Based on surgery, the market can be categorized into ovarian wedge resection, cyst aspiration and laparoscopic ovarian drilling. The laparoscopic ovarian drilling
Regionally, the global PCOS treatment market
Major players operating in the global PCOS treatment market include Bristol-Myers Squibb Company, Bayer AG, Pfizer, Inc., Abbott Laboratories, Inc., Merck & Co., Inc., Sanofi SA, AstraZeneca Plc, Novartis AG, Teva Pharmaceutical Industries Limited, Ferring Pharmaceuticals, Inc., and others. The companies are developing advanced technologies and launching new services in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.
Years considered for this report
Historical Years2015-2018
Base Year2019
Estimated Year2020
Forecast Period2021–2025
Objective of the Study
- To analyze and estimate the market size of global PCOS treatment market from 2015 to 2018.
- To estimate and forecast the market size of global PCOS treatment market from 2019 to 2025 and growth rate until 2025.
- To classify and forecast global PCOS treatment market based on treatment, diagnosis, end user, company and regional distribution.
- To identify dominant region or segment in the global PCOS treatment market.
- To identify drivers and challenges for global PCOS treatment market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global PCOS treatment market.
- To identify and analyze the profile of leading players operating in global PCOS treatment market.
- To identify key sustainable strategies adopted by market players in global PCOS treatment market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of hospitals & clinics, ambulatory surgical centers, fertility clinics across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals & clinics, ambulatory surgical centers, fertility clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the hospitals & clinics, ambulatory surgical centers, fertility clinics and presence of all major players across the globe.
TechSci Research calculated the market size of
Key Target Audience
- PCOS treatment hospitals & clinics, ambulatory surgical centers, fertility centers and other stakeholders
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to PCOS treatment
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals & clinics, ambulatory surgery centers, fertility clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
